Insertion stabilizers for implants
    1.
    发明授权
    Insertion stabilizers for implants 失效
    植入物插入稳定剂

    公开(公告)号:US06692758B1

    公开(公告)日:2004-02-17

    申请号:US09806151

    申请日:2001-03-28

    IPC分类号: A61K31663

    摘要: The present invention relates to an implant attachment stabilizer having, as an effective component, a methanebisphosphonic acid derivative represented by general formula (I) [where, in the formula, X, Y, m, n, , A, B, R1, R2, R3 and R4 are as defined in the Specification], or hydrate thereof. The methanebisphosphonic acid derivatives represented by general formula (I) or the hydrates thereof, to which the present invention relates, have an interstitial tissue proliferation inhibiting action and an osteolytic factor production inhibiting action and, in particular, since they inhibit osteolysis through the inhibition of the interstitial tissue proliferation which accompanies implant attachment and the inhibition of osteolysis factor production at the implant periphery, they are effective in the prevention of implant loosening and detachment, and it is possible to extend the implant attachment period in the case of implants such as artificial joints, and implants in the oro-dental field.

    摘要翻译: 本发明涉及具有通式(I)表示的甲烷二膦酸衍生物作为有效成分的植入物附着稳定剂[式中,X,Y,m,n,,A,B,R 1,R 2,R 本发明涉及的通式(I)表示的甲烷二膦酸衍生物或其水合物具有间质组织增殖抑制作用 并且特别是由于它们通过抑制伴随植入物附着的间质组织增殖和抑制植入物周围的骨质疏松因子产生而抑制骨质溶解,因此它们有效地防止植入物松动和 脱离,它是可能的 e以在诸如人造关节的植入物和牙科领域中的植入物的情况下延长植入物固定周期。

    Drugs for periodontal disease
    2.
    发明授权
    Drugs for periodontal disease 失效
    药物用于牙周病

    公开(公告)号:US06670343B1

    公开(公告)日:2003-12-30

    申请号:US09787182

    申请日:2001-05-29

    IPC分类号: A61K31663

    摘要: An agent for periodontal disease includes, as an active component, a methanebisphosphonic acid derivative or a hydrate thereof represented by the general formula (I): [wherein X, Y, m, n, The methanebisphosphonic acid derivative represented by the general formula (I) or a hydrate thereof according to the present invention has activities such as inhibitory effect on cell infiltration to the affected part associated with periodontal disease, and is useful for the prophylaxis or treatment of periodontal disease.

    摘要翻译: 作为牙周病的药剂,可以举出通式(I)表示的甲烷二膦酸衍生物或其水合物作为活性成分:[其中,X,Y,m,n,由通式(I)表示的甲烷二膦酸衍生物 )或其水合物具有诸如对与牙周病相关的患部的细胞浸润的抑制作用的活性,并且可用于预防或治疗牙周病。

    Remedies for intramedullary diseases
    3.
    发明授权
    Remedies for intramedullary diseases 失效
    治疗髓内疾病

    公开(公告)号:US06555529B1

    公开(公告)日:2003-04-29

    申请号:US09380090

    申请日:1999-08-25

    IPC分类号: A61K3166

    摘要: The present invention has the objective of offering drug for treating abnormalities in bone marrow which corrects the biological balance in the bone marrow, in particular which has the effect of suppressing inflammatory cell infiltration and suppressing cell growth-differentiation factor increase. The present invention relates to drug for treating abnormalities in bone marrow which has, as an effective component, a methanebisphosphonic acid derivative, ester thereof, medicinally acceptable salt thereof, or a hydrate of these. The methanebisphosphonic acid derivatives of the present invention show an outstanding bone marrow abnormality therapeutic effect, so efficacy can be expected in the prevention and treatment of rheumatoid arthritis, multiple myeloma, osteomyelitis and other bone marrow abnormalities. Furthermore, application can also be expected in the prevention and treatment of hypoplastic anaemia, myelocytic leukaemia and other such haematopoietic disorders.

    摘要翻译: 本发明的目的是提供一种用于治疗骨髓中异常的药物,其用于校正骨髓中的生物平衡,特别是其具有抑制炎性细胞浸润和抑制细胞生长分化因子增加的作用。本发明涉及 作为有效成分的甲烷二膦酸衍生物,其酯,药学上可接受的盐或其水合物的骨髓中异常的药物。本发明的甲烷二膦酸衍生物显示出优异的骨髓异常治疗效果 因此预防和治疗类风湿性关节炎,多发性骨髓瘤,骨髓炎等骨髓异常的疗效。 此外,还可以预期在预防和治疗发育不全的贫血,骨髓性白血病和其他这种造血障碍中的应用。

    Interleukin-6 production inhibitors
    4.
    发明授权
    Interleukin-6 production inhibitors 失效
    白细胞介素-6产生抑制剂

    公开(公告)号:US06579860B1

    公开(公告)日:2003-06-17

    申请号:US09623014

    申请日:2000-09-27

    IPC分类号: A61K31663

    CPC分类号: A61K31/663 A61K31/675

    摘要: An interleukin-6 production inhibitor is provided containing a methanebisphosphonic acid derivative as an active component, which has inhibitory effects on interleukin-6 production and is useful in prevention and treatment of diseases due to abnormal production of the interleukin-6. This pharmaceutical is anticipated to have effects in prevention and treatment of diseases related to the interleukin-6, for example, thrombocytosis, inflammatory diseases, abnormal immune response diseases, osteoporosis, rheumatoid arthritis, hypercalcemia, multiple myeloma, cachexia, and nephritis.

    摘要翻译: 提供了含有作为活性成分的甲烷二膦酸衍生物的白细胞介素-6产生抑制剂,其对白细胞介素-6产生具有抑制作用,并且可用于预防和治疗由于白细胞介素-6异常产生引起的疾病。 预期该药物可预防和治疗与白细胞介素-6相关的疾病,例如血小板增多症,炎性疾病,异常免疫应答疾病,骨质疏松症,类风湿性关节炎,高钙血症,多发性骨髓瘤,恶病质和肾炎。